Published in Infect Immun on June 01, 2002
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J Bacteriol (2006) 1.39
Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection. Infect Immun (2006) 1.28
Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect Immun (2003) 1.10
Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol (2005) 1.06
Genomic-scale analysis of bacterial gene and protein expression in the host. Emerg Infect Dis (2004) 1.00
Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis. Cell Microbiol (2011) 0.99
Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun (2006) 0.96
Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials. Front Cell Infect Microbiol (2014) 0.95
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis (2006) 0.89
Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect Immun (2005) 0.86
Kinematics of intracellular chlamydiae provide evidence for contact-dependent development. J Bacteriol (2009) 0.86
Membrane vesicle production by Chlamydia trachomatis as an adaptive response. Front Cell Infect Microbiol (2014) 0.83
Laboratory diagnosis of persistent human chlamydial infection. Front Cell Infect Microbiol (2013) 0.82
Potential problems inherent in cell-based stable NF-kappaB-GFP reporter systems. Mol Cell Biochem (2008) 0.77
Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns. Clin Vaccine Immunol (2010) 0.75
Tryptophan Codon-Dependent Transcription in Chlamydia pneumoniae during Gamma Interferon-Mediated Tryptophan Limitation. Infect Immun (2016) 0.75
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res (2000) 8.69
Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet (1999) 5.81
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med (1996) 2.72
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA. Nucleic Acids Res (2000) 2.16
Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91
Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies. J Clin Pathol (1998) 1.64
Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels. Methods Mol Biol (1999) 1.64
Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis (1999) 1.53
Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun (1995) 1.45
Proteome analysis of the Chlamydia pneumoniae elementary body. Electrophoresis (2001) 1.41
Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism. J Infect Dis (1998) 1.25
Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun (2001) 1.18
Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun (2001) 1.13
Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun (1998) 1.10
Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathog (2001) 1.10
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
Chlamydia pneumoniae and atherosclerosis--an update. Scand J Infect Dis Suppl (1997) 1.04
Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun (2000) 0.98
Effects of interferon gamma on Chlamydia trachomatis serovar A and L2 protein expression investigated by two-dimensional gel electrophoresis. Electrophoresis (1999) 0.87
Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect Immun (2000) 0.84
Differential protein expression by Pseudomonas fragi submitted to various stresses. Electrophoresis (1999) 0.81
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis (2011) 5.42
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes (2009) 3.16
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med (2005) 2.51
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest (2009) 2.34
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med (2002) 2.10
A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 2.08
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis (2006) 2.04
Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab (2004) 2.03
Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol (2002) 1.92
Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem (2003) 1.90
Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem (2002) 1.73
Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem (2003) 1.70
Differential expression of proteins in renal cortex and medulla: a proteomic approach. Kidney Int (2002) 1.61
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis (2005) 1.58
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int (2002) 1.56
Proteomic identification of 14-3-3zeta as a mitogen-activated protein kinase-activated protein kinase 2 substrate: role in dimer formation and ligand binding. Mol Cell Biol (2003) 1.53
Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging (2005) 1.52
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int (2010) 1.52
Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils. J Immunol (2003) 1.50
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging (2005) 1.50
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther (2006) 1.44
Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med (2009) 1.40
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis (2008) 1.38
Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis (2007) 1.32
Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J Neurotrauma (2007) 1.30
Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol Cell Proteomics (2005) 1.25
An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res (2007) 1.23
Splice variants of neuronal nitric oxide synthase are present in the rat kidney. Nephrol Dial Transplant (2008) 1.21
Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics Clin Appl (2009) 1.19
Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. Am J Physiol Renal Physiol (2009) 1.19
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther (2012) 1.17
Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging (2006) 1.17
Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients. Alcohol Res Health (2010) 1.13
Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice. Am J Physiol Renal Physiol (2007) 1.11
Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiol Aging (2005) 1.09
Effects of ACE inhibition on proximal tubule sodium transport. Am J Physiol Renal Physiol (2005) 1.09
Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant (2003) 1.07
Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res (2005) 1.06
Urinary proteomics and biomarker discovery for glomerular diseases. Contrib Nephrol (2004) 1.06
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol (2004) 1.05
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis (2012) 1.05
Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis. J Biol Chem (2003) 1.04
Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J Clin Microbiol (2004) 1.04
Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis (2011) 1.04
Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med (2005) 1.03
Global changes in the epidemiology of community-acquired pneumonia. Semin Respir Crit Care Med (2012) 1.03
Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2012) 1.03
Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment. Chest (2003) 1.02
Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections. J Immunol (2008) 1.01
Evaluation of the knowledge-sharing social network of hospital-based infection preventionists in Kentucky. Am J Infect Control (2011) 0.99
Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol (2008) 0.99
Synthesis and secretion of hemoglobin by retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 0.99
Increases in c-Jun N-terminal kinase/stress-activated protein kinase and p38 activity in monocyte-derived macrophages following the uptake of Legionella pneumophila. Infect Immun (2004) 0.97
Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun (2006) 0.96
Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med (2013) 0.96
Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem (2002) 0.96
Sample preparation for 2-D proteomic analysis. Contrib Nephrol (2004) 0.96
Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem (2002) 0.96
Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res Mol Brain Res (2005) 0.96
Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas. Atherosclerosis (2007) 0.95
Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. J Alzheimers Dis (2006) 0.95
Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia. J Neurochem (2002) 0.95
Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med (2006) 0.94
Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates. J Biol Chem (2013) 0.93
Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion. J Immunol (2005) 0.92
Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling. Biochim Biophys Acta (2009) 0.92
Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase. Am J Physiol Heart Circ Physiol (2002) 0.91
Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int (2005) 0.91
Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol (2006) 0.90
Is the United States an outlier in health care and health outcomes? A preliminary analysis. Int J Health Care Finance Econ (2006) 0.90
Proteomics analysis of human astrocytes expressing the HIV protein Tat. Brain Res Mol Brain Res (2005) 0.90
Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Res Mol Brain Res (2005) 0.90
Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int (2013) 0.90
Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections. Microbes Infect (2005) 0.89
Proteomic identification of a large complement of rat urinary proteins. Nephron Exp Nephrol (2003) 0.89
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infection. BMC Infect Dis (2006) 0.89
Renal tubulointerstitial fibrosis in OVE26 type 1 diabetic mice. Nephron Exp Nephrol (2008) 0.89
Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med (2010) 0.89
Proteomics and diabetic nephropathy. Semin Nephrol (2007) 0.88
Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice. PLoS One (2013) 0.88
Calorimetric analysis of the plasma proteome: identification of type 1 diabetes patients with early renal function decline. Biochim Biophys Acta (2013) 0.88